GSK (LSE: GSK) has delivered a 58.4% share price return over the past five years, putting real pressure on the question of whether current earnings justify ...
GSK has delivered a solid multi year share price run, helped by fresh moves in oncology and vaccines, and that raises a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
According to Sharecast on September 18, 2026, Berenberg upgraded GSK from Hold to Buy and lifted its target price on the stock from GBP 20 to GBP 22, arguing that recent business-development ...
Despite a 5% dip from its 18 February one-year traded high, GSKâ s (LSE: GSK) share price has firmed over the past year. Post-Haleon demerger, GSK is a cleaner, more predictable business with strong ...
GSK stock in London traded around 1,858.5 pence on September 15, 2026 after the company agreed a deal worth up to USD 750 million for a blood cancer drug. Berenberg raised its rating to Buy and lifted ...
Harvey Jones backed the GSK share price to spring into life a couple of years ago, but it's still struggling to make headway. Why isn't it doing better? The post Trading below levels seen 25 years ago ...